Altshuler Shaham’s Array Biopharma Inc ARRY Stock Holding History

Altshuler Shaham’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-844	Closed	-$21K	–	415
2019 Q1	$21K	Buy	+844	New	+$17.6K	﹤0.01%	175

Other funds holding ARRY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Altshuler Shaham's ARRY Position: Q2 2019 in Review

Altshuler Shaham sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 844 shares — an estimated $21K sold.

Altshuler Shaham first reported a position in ARRY in Q1 2019 and held it in 1 quarter. The position peaked at $21K in Q1 2019. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

Altshuler Shaham reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
Altshuler Shaham sold 844 Array Biopharma Inc shares in Q2 2019, an estimated $21K.
Altshuler Shaham first reported a position in Array Biopharma Inc in Q1 2019 and held it in 1 quarter.
Altshuler Shaham's Array Biopharma Inc position peaked at $21K in Q1 2019.
318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Altshuler Shaham's 13F filing for Q2 2019, filed 6 Aug 2019.